These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15468761)

  • 1. Cross-validation for linear model with unequal variances in genomic analysis.
    Li L; Chow SC; Smith W
    J Biopharm Stat; 2004 Aug; 14(3):723-39. PubMed ID: 15468761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential selection of variables using short permutation procedures and multiple adjustments: An application to genomic data.
    Azevedo Costa M; de Souza Rodrigues T; da Costa AG; Natowicz R; Pádua Braga A
    Stat Methods Med Res; 2017 Apr; 26(2):997-1020. PubMed ID: 25575544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating dichotomised outcomes in two groups with unequal variances: a distributional approach.
    Sauzet O; Peacock JL
    Stat Med; 2014 Nov; 33(26):4547-59. PubMed ID: 24989698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding the maximum safe dose level for heteroscedastic data.
    Tamhane AC; Logan BR
    J Biopharm Stat; 2004 Nov; 14(4):843-56. PubMed ID: 15587967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal strategies for sequential validation of significant features from high-dimensional genomic data.
    Lohr M; Köllmann C; Freis E; Hellwig B; Hengstler JG; Ickstadt K; Rahnenführer J
    J Toxicol Environ Health A; 2012; 75(8-10):447-60. PubMed ID: 22686304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling and estimating heterogeneous variances in threshold models for ordinal discrete data via Winbugs/Openbugs.
    Foulley JL; Jaffrézic F
    Comput Methods Programs Biomed; 2010 Jan; 97(1):19-27. PubMed ID: 19520453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid L
    Huang HH; Liang Y
    Comput Methods Programs Biomed; 2018 Oct; 164():65-73. PubMed ID: 30195432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A permutation method to assess heterogeneity in external validation for risk prediction models.
    Wang LY; Lee WC
    PLoS One; 2015; 10(1):e0116957. PubMed ID: 25606854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new variance stabilizing transformation for gene expression data analysis.
    Kelmansky DM; Martínez EJ; Leiva V
    Stat Appl Genet Mol Biol; 2013 Dec; 12(6):653-66. PubMed ID: 24133097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unequal group variances in microarray data analyses.
    Demissie M; Mascialino B; Calza S; Pawitan Y
    Bioinformatics; 2008 May; 24(9):1168-74. PubMed ID: 18344518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size calculations for group randomized trials with unequal group sizes through Monte Carlo simulations.
    Shi Y; Lee JH
    Stat Methods Med Res; 2018 Sep; 27(9):2569-2580. PubMed ID: 30103663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
    Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
    Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating Standardized Effect Sizes for Two- and Three-Level Partially Nested Data.
    Lai MH; Kwok OM
    Multivariate Behav Res; 2016; 51(6):740-756. PubMed ID: 27802077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of finite sample size on feature selection and classification: a simulation study.
    Way TW; Sahiner B; Hadjiiski LM; Chan HP
    Med Phys; 2010 Feb; 37(2):907-20. PubMed ID: 20229900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ridle for sparse regression with mandatory covariates with application to the genetic assessment of histologic grades of breast cancer.
    Zhai J; Hsu CH; Daye ZJ
    BMC Med Res Methodol; 2017 Jan; 17(1):12. PubMed ID: 28122498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests that are robust against variance heterogeneity in k x 2 designs with unequal cell frequencies.
    Overall JE; Atlas RS; Gibson JM
    Psychol Rep; 1995 Jun; 76(3 Pt 1):1011-7. PubMed ID: 7568575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating a positive false discovery rate for variable selection in pharmacogenetic studies.
    Li L; Hui S; Pennello G; Desta Z; Todd S; Nguyen A; Flockhart D
    J Biopharm Stat; 2007; 17(5):883-902. PubMed ID: 17885872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical issue of using the variance of the total in the linearization method - In the context of unequal probability sampling.
    Yu J; Vexler A; Jalal K
    Stat Med; 2019 Apr; 38(8):1475-1483. PubMed ID: 30488467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.